Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Yung Yuen, Tom Wai‐Hin Chung et al.|The Lancet|2020Cited by 1.6k
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case seriesIvan Fan-Ngai Hung, Kwok-Yung Yuen, Vincent Chi‐Chung Cheng et al.|The Lancet Infectious Diseases|2020Cited by 131